Labcorp Holdings EPS - Earnings per Share 2012-2026 | LH
Labcorp Holdings annual and quarterly earnings per share history from 2012 to 2026. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Labcorp Holdings EPS for the quarter ending June 30, 2026 was $3.64, a 28.17% increase year-over-year.
- Labcorp Holdings EPS for the twelve months ending June 30, 2026 was $12.09, a 33.15% increase year-over-year.
- Labcorp Holdings 2025 annual EPS was $10.46, a 18.33% increase from 2024.
- Labcorp Holdings 2024 annual EPS was $8.84, a 85.32% increase from 2023.
- Labcorp Holdings 2023 annual EPS was $4.77, a 65.86% decline from 2022.
| Labcorp Holdings Annual EPS | |
|---|---|
| 2025 | $10.46 |
| 2024 | $8.84 |
| 2023 | $4.77 |
| 2022 | $13.97 |
| 2021 | $24.39 |
| 2020 | $15.88 |
| 2019 | $8.35 |
| 2018 | $8.61 |
| 2017 | $11.81 |
| 2016 | $6.82 |
| 2015 | $4.35 |
| 2014 | $5.91 |
| 2013 | $6.25 |
| 2012 | $5.99 |
| 2011 | $5.11 |
| Labcorp Holdings Quarterly EPS | |
|---|---|
| 2026-06-30 | $3.64 |
| 2026-03-31 | $3.35 |
| 2025-12-31 | $1.98 |
| 2025-09-30 | $3.12 |
| 2025-06-30 | $2.84 |
| 2025-03-31 | $2.52 |
| 2024-12-31 | $1.72 |
| 2024-09-30 | $2.00 |
| 2024-06-30 | $2.43 |
| 2024-03-31 | $2.69 |
| 2023-12-31 | $-1.85 |
| 2023-09-30 | $2.11 |
| 2023-06-30 | $2.12 |
| 2023-03-31 | $2.39 |
| 2022-12-31 | $0.97 |
| 2022-09-30 | $3.90 |
| 2022-06-30 | $3.87 |
| 2022-03-31 | $5.23 |
| 2021-12-31 | $5.76 |
| 2021-09-30 | $6.05 |
| 2021-06-30 | $4.76 |
| 2021-03-31 | $7.82 |
| 2020-12-31 | $9.61 |
| 2020-09-30 | $7.17 |
| 2020-06-30 | $2.37 |
| 2020-03-31 | $-3.27 |
| 2019-12-31 | $2.31 |
| 2019-09-30 | $2.25 |
| 2019-06-30 | $1.93 |
| 2019-03-31 | $1.86 |
| 2018-12-31 | $1.57 |
| 2018-09-30 | $3.10 |
| 2018-06-30 | $2.27 |
| 2018-03-31 | $1.67 |
| 2017-12-31 | $6.63 |
| 2017-09-30 | $1.65 |
| 2017-06-30 | $1.78 |
| 2017-03-31 | $1.75 |
| 2016-12-31 | $1.57 |
| 2016-09-30 | $1.71 |
| 2016-06-30 | $1.96 |
| 2016-03-31 | $1.58 |
| 2015-12-31 | $1.15 |
| 2015-09-30 | $1.50 |
| 2015-06-30 | $1.66 |
| 2015-03-31 | $0.04 |
| 2014-12-31 | $1.37 |
| 2014-09-30 | $1.59 |
| 2014-06-30 | $1.64 |
| 2014-03-31 | $1.31 |
| 2013-12-31 | $1.44 |
| 2013-09-30 | $1.63 |
| 2013-06-30 | $1.62 |
| 2013-03-31 | $1.56 |
| 2012-12-31 | $1.27 |
| 2012-09-30 | $1.53 |
| 2012-06-30 | $1.56 |
| 2012-03-31 | $1.63 |
| 2011-12-31 | $1.37 |
| 2011-09-30 | $1.31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $26.010B | $13.952B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.899B | 26.08 |
| CVS Health (CVS) | United States | $113.624B | 11.33 |
| HCA Healthcare (HCA) | United States | $92.600B | 14.40 |
| Elevance Health (ELV) | United States | $89.122B | 13.98 |
| Cencora (COR) | United States | $58.924B | 18.00 |
| Natera (NTRA) | United States | $53.245B | 0.00 |
| Viatris (VTRS) | United States | $19.469B | 6.73 |
| Medpace Holdings (MEDP) | United States | $17.091B | 35.89 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.888B | 0.00 |
| DiDi Global (DIDIY) | China | $16.776B | 184.00 |
| Revvity (RVTY) | United States | $16.007B | 26.81 |
| Solventum (SOLV) | United States | $15.123B | 12.51 |
| Charles River Laboratories (CRL) | United States | $13.274B | 28.09 |
| ICON (ICLR) | Ireland | $12.565B | 17.08 |
| BrightSpring Health Services (BTSG) | United States | $11.235B | 38.63 |
| Avantor (AVTR) | United States | $10.497B | 18.93 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.472B | 83.28 |
| HealthEquity (HQY) | United States | $7.870B | 25.64 |
| Sonic Healthcare (SKHHY) | Australia | $6.732B | 0.00 |
| PACS (PACS) | United States | $6.666B | 22.40 |
| GETINGE (GNGBY) | Sweden | $6.516B | 18.40 |
| CochLear (CHEOY) | Australia | $6.200B | 0.00 |
| MiniMed (MMED) | United States | $6.131B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.021B | 22.77 |
| Sotera Health (SHC) | United States | $5.345B | 22.04 |
| Concentras Parent (CON) | United States | $4.523B | 22.31 |
| Organon (OGN) | United States | $3.592B | 4.56 |
| GeneDx Holdings (WGS) | United States | $3.015B | 280.83 |
| CareDx (CDNA) | United States | $2.785B | 316.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.465B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.107B | 12.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.103B | 0.00 |
| Progyny (PGNY) | United States | $2.082B | 29.49 |
| Establishment Labs Holdings (ESTA) | United States | $2.065B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $2.011B | 12.08 |
| Sonida Senior Living (SNDA) | United States | $1.839B | 0.00 |
| Freenome (FRNM) | United States | $1.838B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.735B | 66.25 |
| Alignment Healthcare (ALHC) | United States | $1.732B | 43.95 |
| Agilon Health (AGL) | United States | $1.497B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Ardent Health (ARDT) | United States | $1.478B | 8.45 |
| Nutex Health (NUTX) | United States | $1.430B | 8.20 |
| Omada Health (OMDA) | United States | $1.251B | 255.38 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.158B | 22.53 |
| Teladoc Health (TDOC) | United States | $1.145B | 0.00 |
| CryoPort (CYRX) | United States | $0.862B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.677B | 0.00 |
| Forward Industries (FWDI) | United States | $0.569B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 10.11 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.378B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.48 |
| Biodesix (BDSX) | United States | $0.308B | 0.00 |
| Embecta (EMBC) | United States | $0.300B | 2.59 |
| So-Young (SY) | China | $0.279B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.101B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.082B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.073B | 8.67 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.036B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |